CIK: 1461466 - Address: Sunesis Pharmaceuticals, Inc., 395 Oyster Point Boulevard, Ste. 400, South San Francisco, CA 94080
3 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret113452-58-56-63-28
S%wins33336710010010072

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/21/15 21:25
7/24/15
SNSSSunesis Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMisfeldt DaytonCADS.d-2,2003.460-636-75216I-81-66-71-25-2-155688-2-33-34-29
8/29/14 18:31
8/27/14
SNSSSunesis Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMisfeldt DaytonCADTS.m-2,3997.981-301-7787I1295817523716270-50-67-68-81
8/12/14 20:49
8/8/14
SNSSSunesis Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMisfeldt DaytonCADTS.m-4,9386.641-744-8993I1293845456185-14129-74-65-79

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact